Scarica l'app Stockscreener
60.17
2.87%
1.68
Pre-mercato:
60.31
0.14
+0.23%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DXCM Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$58.49
Aprire:
$58.35
Volume 24 ore:
6.69M
Relative Volume:
1.08
Capitalizzazione di mercato:
$1.54B
Reddito:
$4.30B
Utile/perdita netta:
$571.50M
Rapporto P/E:
42.12
EPS:
1.4285
Flusso di cassa netto:
$570.80M
1 W Prestazione:
+3.51%
1M Prestazione:
-9.65%
6M Prestazione:
-29.61%
1 anno Prestazione:
-21.11%
Intervallo 1D:
$58.14
$60.48
Intervallo di 1 settimana:
$57.20
$60.85
Portata 52W:
$54.11
$93.25
Dexcom Inc Stock (DXCM) Company Profile
Nome
Dexcom Inc
Settore
Industria
Telefono
(858) 200-0200
Indirizzo
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Confronta DXCM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
60.17 | 22.81B | 4.30B | 571.50M | 570.80M | 1.4285 |
|
ABT
Abbott Laboratories
|
130.00 | 226.11B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
359.52 | 137.72B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.80 | 123.49B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
BSX
Boston Scientific Corp
|
99.22 | 150.85B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
GEHC
Ge Healthcare Technologies Inc
|
71.02 | 32.17B | 20.25B | 2.29B | 1.40B | 4.8366 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-21 | Ripresa | Stifel | Buy |
| 2025-09-08 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-08-21 | Iniziato | Argus | Buy |
| 2025-06-16 | Iniziato | Truist | Buy |
| 2025-05-30 | Iniziato | Goldman | Buy |
| 2025-04-10 | Iniziato | Mizuho | Outperform |
| 2025-02-03 | Aggiornamento | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-07-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | Iniziato | Redburn Atlantic | Neutral |
| 2024-03-12 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-04-17 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2023-01-26 | Iniziato | Wolfe Research | Outperform |
| 2022-10-18 | Iniziato | Barclays | Equal Weight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-15 | Iniziato | Bernstein | Outperform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-03 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-01-19 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2021-10-18 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-07-21 | Ripresa | Cowen | Outperform |
| 2021-05-28 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2021-01-06 | Aggiornamento | UBS | Neutral → Buy |
| 2020-10-02 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | Reiterato | Piper Sandler | Overweight |
| 2020-05-14 | Iniziato | Wells Fargo | Equal Weight |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2019-11-07 | Reiterato | Canaccord Genuity | Buy |
| 2019-11-07 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-10-23 | Iniziato | Stifel | Buy |
| 2018-11-28 | Iniziato | UBS | Neutral |
| 2018-10-19 | Aggiornamento | Goldman | Sell → Neutral |
| 2018-09-12 | Aggiornamento | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | Reiterato | Canaccord Genuity | Buy |
| 2018-07-02 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-05-11 | Iniziato | BofA/Merrill | Buy |
| 2018-05-03 | Reiterato | Canaccord Genuity | Buy |
| 2018-04-04 | Iniziato | Goldman | Sell |
| 2018-04-04 | Iniziato | Guggenheim | Neutral |
| 2018-03-23 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | Downgrade | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | Reiterato | Wedbush | Outperform |
Mostra tutto
Dexcom Inc Borsa (DXCM) Ultime notizie
DexCom Inc. stock outlook for YEAREarnings Recap Report & Fast Entry Momentum Alerts - newser.com
DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class ActionContact Kessler Topaz Meltzer & Check, LLP - FinancialContent
Alberta Investment Management Corp Has $450,000 Position in DexCom, Inc. $DXCM - Defense World
DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
DexCom (DXCM) eyes deeper correction toward $44.11–$20.95 zone - FXStreet
Dexcom Wrongful Death Lawsuit Alleges Continuous Glucose Monitor Failed - AboutLawsuits.com
DXCM LAWSUIT ALERT: Levi & Korsinsky Notifies DexCom, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - WV News
Join Class Action to Recover Losses from DexCom, Inc. (DXCM)Contact Levi & Korsinsky Before December 26, 2025 - ACCESS Newswire
Banco Bilbao Vizcaya Argentaria S.A. Cuts Stock Position in DexCom, Inc. $DXCM - Defense World
Wall Street Zen Downgrades DexCom (NASDAQ:DXCM) to Buy - Defense World
3 Reasons We’re Fans of DexCom (DXCM) - Yahoo Finance
DexCom’s SWOT analysis: diabetes tech leader faces stock headwinds amid growth - Investing.com
Collins Richard Alexander sells Dexcom (DXCM) shares worth $171,599 - Investing.com
Shareholders that lost money on DexCom, Inc. (DXCM) Urged to Join Class Action – Contact Levi ... - Bluefield Daily Telegraph
Shareholders that lost money on DexCom, Inc. (DXCM) Urged - GlobeNewswire
Investors SueWallSt as DexCom, Inc. Faces Securities Fraud Allegations - ACCESS Newswire
Allworth Financial LP Raises Stock Position in DexCom, Inc. $DXCM - Defense World
DXCM Announcement: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against DexCom, Inc. (DXCM) - The Malaysian Reserve
Lowey Dannenberg Notifies DexCom, Inc. (“DexCom” or the - GlobeNewswire
Shareholders that lost money on DexCom, Inc. (DXCM) Urged to Joi - GuruFocus
DEXCOM, INC. (NASDAQ: DXCM) SHAREHOLDER ALERT Bernstein - GlobeNewswire
Shareholders that lost money on DexCom, Inc. (DXCM) Urged to Join Class ActionContact The Gross Law Firm to Learn More - PR Newswire
DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
3 Reasons We're Fans of DexCom (DXCM) - Finviz
ROSEN, A LEADING NATIONAL FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before ... - Bluefield Daily Telegraph
ROSEN, A LEADING NATIONAL FIRM, Encourages DexCom, Inc. - GlobeNewswire
ROSEN, A LEADING NATIONAL FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM - GlobeNewswire Inc.
Is DexCom Inc. (DC4) stock undervalued after correctionPortfolio Growth Summary & Capital Efficiency Focused Ideas - newser.com
DXCM Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. (DXCM) Shareholders of Deadline in Securities Fraud Class Action Lawsuit - Markets Financial Content
DXCM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Will DexCom Inc. stock continue dividend increasesPortfolio Performance Report & Free Fast Gain Swing Trade Alerts - newser.com
Will DexCom Inc. (DC4) stock keep high P E multiplesEarnings Trend Report & Capital Efficient Trade Techniques - newser.com
How Recent Developments Are Reshaping the DexCom Investment Story - Yahoo Finance
Arcadia Investment Management Corp MI Acquires 5,365 Shares of DexCom, Inc. $DXCM - Defense World
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit - Morningstar
Lost Money on DexCom, Inc. (DXCM)? Contact Levi & Korsinsky Before December 26, 2025 to Join Class Action - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
Has DexCom Inc. found a price floor2025 Retail Activity & High Return Stock Watch Alerts - newser.com
Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. Investors With Losses to Contact the Firm - NewMediaWire
DEXCOM, INC. (NASDAQ: DXCM) INVESTOR ALERT Investors With - GlobeNewswire
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Aristotle Atlantic’s Core Equity Strategy Initiated a Position in Dexcom (DXCM) Backed by Its Robust Financial Stability - Insider Monkey
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. LawsuitDXCM - Morningstar
Dexcom Reveals Global Diabetes Advocates: New Voices for Diabetes Awareness This World Diabetes Day - galvnews.com
Levi & Korsinsky Notifies DexCom, Inc. (DXCM) Shareholders of Class Action Lawsuit and December 26, 2025 Deadline - ACCESS Newswire
DexCom, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your Rights – DXCM - MarketScreener
Class Action Alert: Levi & Korsinsky Reminds DexCom, Inc. (DXCM) Investors of December 26, 2025 Deadline - Newsfile
ROSEN, A LEADING LAW FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important ... - Bluefield Daily Telegraph
ROSEN, A LEADING LAW FIRM, Encourages DexCom, Inc. - GlobeNewswire
Frank Sands Reduces Stake in DexCom Inc by 50.4%, Impacting Portfolio by -1.25% - Yahoo Finance
Class Action Announcement for DexCom, Inc. Investors: A Securities Fraud Class Action Lawsuit With Expanded Class Period Was Filed Against CarMax, Inc.Contact Kessler Topaz Meltzer & Check, LLP - NewMediaWire
Dexcom Inc Azioni (DXCM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.26%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):